<DOC>
	<DOCNO>NCT00405548</DOCNO>
	<brief_summary>The purpose research study evaluate effect cardiac hormone replacement SQ ( subcutaneous skin ) injection BNP ( brain natriuretic peptide , hormone produce heart ) pump ability heart , kidney function level different hormone blood response intravenous salt solution .</brief_summary>
	<brief_title>Human Brain Natriuretic Peptide ( BNP ) ( Nesiritide ) Help Heart , Kidney Humoral Function .</brief_title>
	<detailed_description>Prior initiation study , subject stabilize least one week add salt diet ( 120 milliequivalent ( mEq ) Na/Day ) maintain study . Participants study randomize receive BNP placebo ( inactive , saline shot ) . The participant need give shot stomach ( similar diabetic give insulin ) twice day twelve week . The study require screen visit determine eligibility discus study . At visit blood draw heart liver function six minute walk do . There also two outpatient visit two inpatient stay , 48 hour , Clinical Research Unit St. Marys Hospital . During two overnight stay , blood urine sample do get heart kidney function well research echocardiogram . An acute saline load ( 0.9 % normal saline 1.25 ml/kg/min 1 hour ) give blood urine sample collect After enrollment , study last twelve week . It plan treat 2 subject active drug per placebo subject improve precision group comparison .</detailed_description>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>Subjects ejection fraction great 50 % moderate severe diastolic dysfunction assess Doppler echocardiography No sign symptom congestive heart failure hospitalize heart failure Exclusion criterion : Myocardial Infarction ( MI ) within 3 month screen Unstable angina within 14 day screen , evidence myocardial ischemia Significant valvular stenosis , hypertrophic , restrictive obstructive cardiomyopathy , constrictive pericarditis , primary pulmonary hypertension , biopsy proven active myocarditis Severe congenital heart disease Sustained ventricular tachycardia ventricular fibrillation within 14 day screen Second third degree heart block without permanent cardiac pacemaker Stroke within 3 month screen , evidence significantly compromised central nervous system ( CNS ) perfusion Total bilirubin &gt; 1.5 mg/dL liver enzymes &gt; 1.5 time upper limit normal ( mg/dL = milligram per deciliter ) Serum creatinine &gt; 3.0 mg/dL Serum sodium &lt; 125 mEq/dL &gt; 160 mEq/dL ( milliequivalent per deciliter ) Serum potassium &lt; 3.5 mEq/dL &gt; 5.0/dL Serum digoxin level &gt; 2.0 ng/ml ( nanograms per milliliter ) Systolic pressure &lt; 85 mm Hg ( millimeter mercury ) Hemoglobin &lt; 10 gm/dl ( grams per deciliter )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>